News
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its ...
Novo Nordisk stock rose after the Danish pharma giant posted better-than-expected quarterly earnings even as sales of its ...
54m
Investor's Business Daily on MSNNovo Blames Compounders As It Cuts 2025 Forecast. Shares Jump.Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due what Novo says is illegal compounding of GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results